These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 19838218)
1. The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells. Thobe MN; Gurusamy D; Pathrose P; Waltz SE Oncogene; 2010 Jan; 29(2):214-26. PubMed ID: 19838218 [TBL] [Abstract][Full Text] [Related]
2. The Ron receptor promotes prostate tumor growth in the TRAMP mouse model. Thobe MN; Gray JK; Gurusamy D; Paluch AM; Wagh PK; Pathrose P; Lentsch AB; Waltz SE Oncogene; 2011 Dec; 30(50):4990-8. PubMed ID: 21625214 [TBL] [Abstract][Full Text] [Related]
3. Tumor Cell Autonomous RON Receptor Expression Promotes Prostate Cancer Growth Under Conditions of Androgen Deprivation. Brown NE; Paluch AM; Nashu MA; Komurov K; Waltz SE Neoplasia; 2018 Sep; 20(9):917-929. PubMed ID: 30121008 [TBL] [Abstract][Full Text] [Related]
4. G31P, an antagonist against CXC chemokine receptors 1 and 2, inhibits growth of human prostate cancer cells in nude mice. Liu X; Peng J; Sun W; Yang S; Deng G; Li F; Cheng JW; Gordon JR Tohoku J Exp Med; 2012 Oct; 228(2):147-56. PubMed ID: 23019013 [TBL] [Abstract][Full Text] [Related]
5. CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer. Chen C; Xu ZQ; Zong YP; Ou BC; Shen XH; Feng H; Zheng MH; Zhao JK; Lu AG Cell Death Dis; 2019 Feb; 10(3):178. PubMed ID: 30792394 [TBL] [Abstract][Full Text] [Related]
6. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation. Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013 [TBL] [Abstract][Full Text] [Related]
7. PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer. Keshamouni VG; Arenberg DA; Reddy RC; Newstead MJ; Anthwal S; Standiford TJ Neoplasia; 2005 Mar; 7(3):294-301. PubMed ID: 15799829 [TBL] [Abstract][Full Text] [Related]
8. Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer. Nishimura K; Nonomura N; Satoh E; Harada Y; Nakayama M; Tokizane T; Fukui T; Ono Y; Inoue H; Shin M; Tsujimoto Y; Takayama H; Aozasa K; Okuyama A J Natl Cancer Inst; 2001 Nov; 93(22):1739-46. PubMed ID: 11717335 [TBL] [Abstract][Full Text] [Related]
9. Cyclic AMP-responsive element binding protein- and nuclear factor-kappaB-regulated CXC chemokine gene expression in lung carcinogenesis. Sun H; Chung WC; Ryu SH; Ju Z; Tran HT; Kim E; Kurie JM; Koo JS Cancer Prev Res (Phila); 2008 Oct; 1(5):316-28. PubMed ID: 19138976 [TBL] [Abstract][Full Text] [Related]
10. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells. Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933 [TBL] [Abstract][Full Text] [Related]
11. A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells. Chakedis J; French R; Babicky M; Jaquish D; Howard H; Mose E; Lam R; Holman P; Miyamoto J; Walterscheid Z; Lowy AM Oncogene; 2016 Jun; 35(25):3249-59. PubMed ID: 26477314 [TBL] [Abstract][Full Text] [Related]
12. The RON tyrosine kinase receptor regulates vascular endothelial growth factor production in pancreatic cancer cells. Thomas RM; Jaquish DV; French RP; Lowy AM Pancreas; 2010 Apr; 39(3):301-7. PubMed ID: 20358644 [TBL] [Abstract][Full Text] [Related]
13. Progressive dysregulation of transcription factors NF-kappa B and STAT1 in prostate cancer cells causes proangiogenic production of CXC chemokines. Shen H; Lentsch AB Am J Physiol Cell Physiol; 2004 Apr; 286(4):C840-7. PubMed ID: 14656722 [TBL] [Abstract][Full Text] [Related]
14. NDRG3 is an androgen regulated and prostate enriched gene that promotes in vitro and in vivo prostate cancer cell growth. Wang W; Li Y; Li Y; Hong A; Wang J; Lin B; Li R Int J Cancer; 2009 Feb; 124(3):521-30. PubMed ID: 18975380 [TBL] [Abstract][Full Text] [Related]
15. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA). Reddy KRK; Dasari C; Duscharla D; Supriya B; Ram NS; Surekha MV; Kumar JM; Ummanni R Angiogenesis; 2018 Feb; 21(1):79-94. PubMed ID: 29150732 [TBL] [Abstract][Full Text] [Related]
16. The prostate transglutaminase, TGase-4, coordinates with the HGFL/MSP-RON system in stimulating the migration of prostate cancer cells. Jiang WG; Ye L; Ablin RJ; Kynaston HG; Mason MD Int J Oncol; 2010 Aug; 37(2):413-8. PubMed ID: 20596668 [TBL] [Abstract][Full Text] [Related]
17. Gα-13 induces C Lim WK; Chai X; Ghosh S; Ray D; Wang M; Rasheed SAK; Casey PJ J Biol Chem; 2019 Nov; 294(48):18192-18206. PubMed ID: 31636124 [TBL] [Abstract][Full Text] [Related]
18. Ron receptor tyrosine kinase negatively regulates TNFalpha production in alveolar macrophages by inhibiting NF-kappaB activity and Adam17 production. Nikolaidis NM; Gray JK; Gurusamy D; Fox W; Stuart WD; Huber N; Waltz SE Shock; 2010 Feb; 33(2):197-204. PubMed ID: 19487969 [TBL] [Abstract][Full Text] [Related]
19. Knockdown of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and reduces metastasis in human colon carcinoma. Wang J; Rajput A; Kan JL; Rose R; Liu XQ; Kuropatwinski K; Hauser J; Beko A; Dominquez I; Sharratt EA; Brattain L; Levea C; Sun FL; Keane DM; Gibson NW; Brattain MG J Biol Chem; 2009 Apr; 284(16):10912-22. PubMed ID: 19224914 [TBL] [Abstract][Full Text] [Related]
20. High C-X-C motif chemokine 5 expression is associated with malignant phenotypes of prostate cancer cells via autocrine and paracrine pathways. Qi Y; Zhao W; Li M; Shao M; Wang J; Sui H; Yu H; Shao W; Gui S; Li J; Jia X; Jiang D; Li Y; Zhang P; Wang S; Wang W Int J Oncol; 2018 Jul; 53(1):358-370. PubMed ID: 29749439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]